R
RECOMBINETICS
Biotech & Life Sciences · Minneapolis, United States · Founded 2008
Recombinetics uses gene editing technology to develop solutions for various biomedical and agricultural applications MoreLess
Recombinetics is a pioneering company in the field of gene editing technology, focusing on improving human health and agricultural productivity. The company operates in the biopharmaceutical and agricultural sectors, serving clients ranging from healthcare providers to agricultural producers. Recombinetics' business model revolves around the development and application of gene editing techniques to create advanced disease models for regenerative medicine and precision breeding solutions for livestock. By leveraging cutting-edge genetic science, the company aims to extend human lifespans, enhance the quality of life, and increase agricultural yields while reducing animal suffering. Revenue is generated through partnerships, licensing agreements, and direct sales of their innovative genetic solutions.
Keywords: gene editing, human health, agriculture, disease models, regenerative medicine, precision breeding, biopharma, livestock, genetic science, innovation.
Company overview
RECOMBINETICS company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2008
- Headquarters
- Minneapolis, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 66.2
Valuation & funding
RECOMBINETICS funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2018 | $34M | $136M | Undisclosed | ↗ |
| SEED✓Equity / VC | Jan 2018 | — | — | Undisclosed | — |
| SEED✓Equity / VC | Oct 2017 | $0 | — | Undisclosed | — |
| DEBT✓Debt | Apr 2017 | $0 | — | Undisclosed | — |
| SEED✓Equity / VC | Nov 2016 | $0 | — | Undisclosed | — |
| SEED✓Equity / VC | Aug 2016 | Undisclosed | — | ||
| SEED✓Equity / VC | Oct 2014 | Undisclosed | — | ||
| SEED✓Equity / VC | Aug 2013 | Undisclosed | — | ||
| SERIES A✓Equity / VC | Jun 2013 | Undisclosed | — | ||
| SPINOUT✓Other financing | Aug 2008 | University of Minnesota Twin Cities | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 17 |
| 2025 | 20 |
| 2024 | 25 |
| 2023 | 30 |
| 2022 | 33 |
| 2021 | 35 |
| 2020 | 36 |
Growth signals
RECOMBINETICS website traffic
Latest recorded traffic for RECOMBINETICS is 870 monthly website visits, down 13% over the last three months. RECOMBINETICS's team declined 15% over the past year.
Comparisons
RECOMBINETICS compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
RECOMBINETICS's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where RECOMBINETICS has talent and traffic
team presence
In the news
Latest news about RECOMBINETICS
Recent press, funding announcements, and product moves mentioning RECOMBINETICS — open to read from the original sources.
Market sentiment
What the market is saying about RECOMBINETICS
An AI-synthesized read of the highest-engagement posts about RECOMBINETICS on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RECOMBINETICS’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.